花旗集团调整了对英特格拉生命科学控股公司的股票评级,将其从“卖出”上调至“中性”。与此同时,该行将其目标股价从11美元大幅调升至16美元。
花旗集团调整了对英特格拉生命科学控股公司的股票评级,将其从“卖出”上调至“中性”。与此同时,该行将其目标股价从11美元大幅调升至16美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.